Nav: Home

Study finds no association between trazodone and reduced dementia risk

February 05, 2019

In a large UK population-based study, Ian Wong and colleagues at the University of Hong Kong and University College London, UK, found no statistically significant association between the antidepressant trazodone and a reduced risk of dementia when compared to other antidepressants. Their findings were published this week in PLOS Medicine.

In vitro and animal studies have previously suggested that trazodone may protect against dementia. In the new study, researchers analyzed data from the Health Improvement Network (THIN), which includes medical records of over 15 million primary care patients in the UK. They identified 4,716 people over the age of 50 years who received at least two consecutive trazodone prescriptions between 2000 and 2017, and compared them with 420,280 users of other antidepressants with similar baseline characteristics.

The median time to dementia diagnosis for trazodone users was 1.8 years. The incidence of dementia among trazodone users was higher than in matched antidepressant users (1.8 vs 1.1 dementia cases per 100 person-years) with a hazard ratio of 1.80 (95% confidence interval 1.56-2.09, P < 0.001). However, the results do not point toward a causal association; the study is limited by the fact that people in the prodromal stage of dementia might be preferentially prescribed trazodone.

"These results refute the suggestions from animal studies that trazodone might stop or delay the onset of dementia in patients at the prodromal stage of dementia," the authors say.
-end-
Research Article

Funding:

RB is funded by a UCL Maplethorpe Fellowship and the collaboration between the Department of Pharmacology and Pharmacy of the University of Hong Kong, and the UCL School of Pharmacy is funded by The University of Hong Kong-University College London (HKU-UCL) Strategic Partnership Fund. JFH is funded by a Wellcome Trust Clinical Research Career Development Fellowship. JFH, DPJO, and RH are supported by the UCLH NIHR Biomedical Research Center.

Competing Interests:

I have read the journal's policy and the authors of this manuscript have the following competing interests: ICKW has received research funding from Bristol-Myers Squibb, Pfizer, Janssen, the Hong Kong Research Grants Council, and the Hong Kong Health and Medical Research Fund unrelated to the submitted work. JK is an employee of IQVIA. There are no other relationships or activities that could appear to have influenced the submitted work.

Citation:

Brauer R, Lau WCY, Hayes JF, Man KKC, Osborn DPJ, Howard R, et al. (2019) Trazodone use and risk of dementia: A population-based cohort study. PLoS Med 16(2): e1002728. https://doi.org/10.1371/journal.pmed.1002728

Image Credit: Snr Airman Kristin High, U.S. Air Force

Author Affiliations:

Research Department of Practice and Policy, UCL School of Pharmacy, London, United Kingdom
Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy,
Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong
Division of Psychiatry, University College London, London, United Kingdom
Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
Department of Social Work and Social Administration, Faculty of Social Science, The University of Hong Kong, Hong Kong
Centre of Excellence for Retrospective Studies, Real World Insights, IQVIA, London, United Kingdom
Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom
The University of Hong Kong, Shenzhen Hospital, Shenzhen, Guangdong, China

In your coverage please use this URL to provide access to the freely available paper: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002728

PLOS

Related Dementia Articles:

Digital solutions for dementia care
Telehealth delivery of dementia care in the home can be as effective as face-to-face home visit services if carers and recipients take advantage of the technologies available, Australian researchers say.
Despite a marked reduction in the prevalence of dementia, the number of people with dementia is set to double by 2050 according to new Alzheimer Europe report
Today, at a European Parliament lunch debate, Alzheimer Europe launched a new report presenting the findings of its collaborative analysis of recent prevalence studies and setting out updated prevalence rates for dementia in Europe.
Inflammatory marker linked to dementia
Higher levels of an inflammatory marker, sCD14, were associated with brain atrophy, cognitive decline and dementia in two large heart studies.
How likely do you think you are to develop dementia?
A poll suggests almost half of adults ages 50 to 64 believe they're likely to develop dementia.
Latest issue of Alzheimer's & Dementia
Predicting heart disease might also be a warning sign for Alzheimer's; A new way to think about the environment and Alzheimer's research; Most dementia patients don't receive care from physicians who specialize in brain health.
What multilingual nuns can tell us about dementia
A strong ability in languages may help reduce the risk of developing dementia, says a new University of Waterloo study.
Brain changes may help track dementia, even before diagnosis
Even before a dementia diagnosis, people with mild cognitive impairment may have different changes in the brain depending on what type of dementia they have, according to a study published in the September 11, 2019, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Could marriage stave off dementia?
Dementia and marital status could be linked, according to a new Michigan State University study that found married people are less likely to experience dementia as they age.
Migraine diagnoses positively associated with all-cause dementia
Several studies have recently focused on the association between migraine headaches and other headaches and dementia and found a positive migraine-dementia relationship.
Apathy: The forgotten symptom of dementia
Apathy is the most common neuropsychiatric symptom of dementia, with a bigger impact on function than memory loss -- yet it is under-researched and often forgotten in care.
More Dementia News and Dementia Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.